Cigna, a major insurer, is capping monthly insulin costs at $25. It’s a Band-Aid on a much bigger problem. (2019)
DIYers used a security flaw to bypass the $8.3 billion insulin delivery business with a cobbled-together artificial pancreas. (2018)
Evidence from tissue studies and some people with COVID-19 shows that the virus damages insulin-producing cells. (2020)